Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olopatadine/Ketorolac FDC vs Olopatadine in Seasonal Allergic Conjunctivitis
NCT01258309Phase 3Completed
- Sponsor
- Allergan
- Start
- Dec 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olopatadine + ketorolac in seasonal allergic conjunctivitis (SAC), sponsored by Allergan. Started Dec 2010; status: completed.
02
Drugs
olopatadine + ketorolac
03
Conditions
seasonal allergic conjunctivitis (SAC)
Beyond the preview
Go deeper on NCT01258309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01258309.